Background: Liver is the second most commonly involved organ in druginduced systemic hypersensitivity reactions (DiSH). Although liver function is very important indicator in the course of DiSH, there have been few studies about the characteristics of the liver injury. In present study, we investigated clinical characteristics of DiSH associated with liver injury (liver-DiSH) Methods: We retrospectively reviewed medical records of 38 hospitalized patients who developed liver-DiSH (AST or ALT $80 IU/L) from January 2008 to February 2011 in a tertiary referral hospital. We analyzed culprit drugs, the type and degree of liver injury, and the effect of systemic corticosteroids. Fisher's exact test and Chi-square test and Mann-Whitney test were used for statistical analysis. Results: Thirty-eight patients of liver-DiSH were enrolled, whose clinical phenotypes were Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/ TEN) (n ¼ 9, 24%), drug reaction with eosinophilia and systemic symptoms (DRESS) (n ¼ 23, 60%), maculopapular rash (MP rash) (n ¼ 5, 13%) and acute generalized exanthematous pustulosis (AGEP) (n ¼ 1, 3%). Antibiotics (n ¼ 16/ 38, 41%) was the most common cause of liver-DiSH. Culprit agents of liverDiSH were allopurinol (n ¼ 3/9, 33%) in SJS/TEN and antibiotics (n ¼ 13/23, 57%) in DRESS. Mortality tended to be higher in SJS/TEN than in DRESS (22% (2/9) vs 17% (4/23), P ¼ 0. Results: Twenty-nine cases were validated as probable or definitive DRESS, 20 females (69%) and the mean age was 43.6. The reactions generally started with fever and exanthema. All cases had exanthema, mucosal involvement was found in 4 patients (13%). Fever .388C was present in 89% and lymphadenopathy in 55%. Involvement of a single internal organ (69%) or variable combination of 2 or more internal organs (17%) was common, predominantly related to liver (79%), kidney (17%) and lung (6.8%). Eighty percent of patients with renal involvement required dialysis. Eosinophilia was documented in 89% and atypical lymphocytes in 31%. Sixty-nine percent were related with antiepileptics, 10% with sulfonamides and 6.8% with allopurinol, 6.8% with b-lactams antibiotics and 6.8% with non-steroidal anti-inflammatory drugs. The mean interval between the intake of the suspected drug and the reaction was 27.6. In all patients the duration of the reaction was protracted (.15 days). Forty-eight patients reported the intake of more than 2 drugs at the same time of the reaction, but in all cases there was 01 drug suspected. No fatalities occurred. Conclusions: This series confirmed the clinical variability of DRESS, highlighting skin, fever, lymphadenopathy, internal organs involvement and eosinophilia. There was severe internal organ involvement, but no fatalities occurred. Clinical characters and time of onset of the reactions differs from others non-immediate hypersensitivity reactions, it supports that DRESS is an original phenotype. Prospective long-term multicentric epidemiological studies may be important for better understanding of this syndrome. Background: Among the milk whey proteins, b-lactoglobulin (b-Lg) is the main allergen. In native state, b-Lg is resistant to pepsin, which is considered an indicator of its allergenic potential. Protein antigenicity can be reduced by treatment with transglutaminase (TG), an enzyme which catalyses inter or intra crosslink between Lys and Gln residues. Reducing agents have been used to increase the access of TG to the Lys and Gln residues. This study aimed at investigating the antigenicity and digestibility by pepsin of b-Lg modified by TG in the presence of the reducing agent glutathione (GSH). Methods and Results: The polymerization of b-Lg (Davisco, MN, USA) by microbial TG (WM, Ajinomoto Ltda, Brazil) was studied using a central-composite experimental design with 2 independent variables, GSH concentration [GSH] (0-0.2 mmol L 21 ) and enzyme:substrate ratio (E/S) (0-44.1 U g 21 ). The dependent variable was the response of specific IgE obtained from the serum of BALB/c mice sensitized with native b-Lg (IgE anti-b-Lg) against the modified protein. Polymerization was carried out at 508C/180 minutes and stopped by heating at 808C/5 min. Digestion was simulated using pepsin (E/S 1:20 w/w, pH 2, 378C, 1 hour), and SDS-PAGE and the ELISA assay used to characterize and evaluate the antigenicity of the samples, respectively. The linear and quadratic factors of [GSH] and E/S, and their interaction, showed no significant effect on the response of lgE. No treatment resulted in a decrease in the response of IgE anti-b-Lg, but a significant (P , 0.05) increase was observed in the response of IgE against treatments 1, 7 and center point. Intact b-Lg was observed in the electrophoretic profile of the digested samples, indicating resistance to pepsin. After digestion, the samples not presented difference with respect to the digested native b-Lg sample (213.06 6 9.59 ng mL 21 ). Conclusion: Polymerization of the b-Lg with TG in the presence of the GSH did not alter its digestibility by pepsin or decrease the antigenicity. Under some of the conditions studied the antigenicity of the b-Lg increased, indicating that the treatment could have created or exposed epitopes.
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